ES2145360T3 - Sales cristalinas y estables de acido tetrahidrofolico. - Google Patents

Sales cristalinas y estables de acido tetrahidrofolico.

Info

Publication number
ES2145360T3
ES2145360T3 ES96116403T ES96116403T ES2145360T3 ES 2145360 T3 ES2145360 T3 ES 2145360T3 ES 96116403 T ES96116403 T ES 96116403T ES 96116403 T ES96116403 T ES 96116403T ES 2145360 T3 ES2145360 T3 ES 2145360T3
Authority
ES
Spain
Prior art keywords
stable
crystalline salts
tetrahydropholic
acid
tetrahydropholic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96116403T
Other languages
English (en)
Inventor
Hans Rudolf Muller
Rudolf Moser
Martin Ulmann
Thomas Ammann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eprova AG
Original Assignee
Eprova AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eprova AG filed Critical Eprova AG
Application granted granted Critical
Publication of ES2145360T3 publication Critical patent/ES2145360T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

LA INVENCION TRATA DE SALES ESTABLES CRISTALINAS DEL ACIDO (6R,S)-, (6S)-, Y (6R)-TETRAHIDROFOLICO, PROCEDIMIENTO DE OBTENCION DE ESTAS SALES Y SU UTILIZACION COMO COMPONENTE PARA LA OBTENCION DE MEDICAMENTOS Y PREPARACIONES FARMACEUTICAS QUE CONTIENEN ESTAS SALES.
ES96116403T 1995-11-07 1996-10-14 Sales cristalinas y estables de acido tetrahidrofolico. Expired - Lifetime ES2145360T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH03145/95A CH689831A5 (de) 1995-11-07 1995-11-07 Stabile kristalline Tetrahydrofolsaeure-Salze.

Publications (1)

Publication Number Publication Date
ES2145360T3 true ES2145360T3 (es) 2000-07-01

Family

ID=4249585

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96116403T Expired - Lifetime ES2145360T3 (es) 1995-11-07 1996-10-14 Sales cristalinas y estables de acido tetrahidrofolico.

Country Status (19)

Country Link
US (1) US5817659A (es)
EP (1) EP0773221B1 (es)
JP (1) JP3382103B2 (es)
KR (2) KR100296162B1 (es)
CN (1) CN1067392C (es)
AT (1) ATE191482T1 (es)
AU (1) AU707443B2 (es)
CA (1) CA2187409C (es)
CH (1) CH689831A5 (es)
DE (1) DE59604878D1 (es)
DK (1) DK0773221T3 (es)
ES (1) ES2145360T3 (es)
GR (1) GR3033727T3 (es)
HU (1) HUP9603072A3 (es)
NO (1) NO964699L (es)
PT (1) PT773221E (es)
RU (1) RU2187508C2 (es)
TW (1) TW533214B (es)
ZA (1) ZA969284B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
AU1223400A (en) * 1998-10-22 2000-05-08 Phillip B. B. Moheno Novel pterin antineoplastic agents
CH693905A5 (de) * 1999-04-15 2004-04-15 Eprova Ag Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH694251A5 (de) 1999-07-14 2004-10-15 Eprova Ag Herstellung von Tetrahydropterin und Derivaten.
FR2816944B1 (fr) * 2000-11-17 2005-10-21 Dospharma Nouveaux sels de lithium, les compositions pharmaceutiques a base de ces sels de lithium et leurs applications comme medicament
ATE498401T1 (de) * 2004-09-15 2011-03-15 Nipro Corp Wässrige, stabile (6s)-folinsäurelösung zur injektion
ES2538480T3 (es) * 2008-02-20 2015-06-22 Gnosis S.P.A. Folatos, composiciones y usos de los mismos
US7947662B2 (en) 2008-02-20 2011-05-24 Gnosis S.P.A. Folates, compositions and uses thereof
US9629846B1 (en) 2013-11-14 2017-04-25 Argent Development Group, Llc Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
US9492421B1 (en) 2013-11-14 2016-11-15 Argent Development Group, Llc Nutritional supplements for treatment of iron deficiency anemia
WO2016185413A1 (en) 2015-05-20 2016-11-24 Nestec S.A. Modified release formulations
JP7296885B2 (ja) 2017-03-31 2023-06-23 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング ５－メチル－（６ｓ）－テトラヒドロ葉酸の結晶性ナトリウム塩
PT3609894T (pt) 2017-03-31 2024-08-29 Merck Patent Gmbh Sal de sódio cristalino do ácido 5-metil-(6s)-tetrahidrofólico
EP3461826A1 (en) 2017-09-29 2019-04-03 Aprofol AG Multifunctional folate salts
CN108976232A (zh) * 2018-09-19 2018-12-11 江苏红豆杉药业有限公司 一种四氢叶酸钙的合成方法
EP3646873A1 (en) 2018-10-31 2020-05-06 Aprofol AG Folate salts
CN109456330B (zh) * 2018-11-26 2021-05-14 连云港德洋化工有限公司 叶酸类稳定复合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124452A (en) * 1978-07-10 1992-06-23 Bioresearch S.P.A. Process for producing d,1-5-methyltetrahydrofolic acid and its salts
MX169933B (es) * 1987-09-18 1993-08-02 Hideaki Yamada Procedimiento para la produccion biologica de amidas
DE3821875C1 (es) * 1988-06-29 1990-02-15 Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
CH681303A5 (es) * 1991-01-16 1993-02-26 Eprova Ag
CH684270A5 (de) * 1991-10-04 1994-08-15 Sapec Fine Chemicals Verfahren zur Herstellung von Erdalkalimetallsalzen von (6R)-N(10)-Formyl-5,6,7,8-tetrahydrofolsäure.
CH686672A5 (de) * 1992-12-01 1996-05-31 Cerbios Pharma Sa Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure.
GEP20012441B (en) * 1993-04-02 2001-05-25 Lonza Ag Process for Preparing 3-Methylpiperidine and 3-Methylpyridine
CH686369A5 (de) * 1994-05-09 1996-03-15 Eprova Ag Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
CZ338596A3 (en) * 1994-05-23 1997-07-16 Lonza Ag Catalytic mixture for oxidative amonolysis of alkyl pyridines, process of its preparation and use

Also Published As

Publication number Publication date
HUP9603072A2 (en) 1997-08-28
ZA969284B (en) 1997-05-07
GR3033727T3 (en) 2000-10-31
KR100702201B1 (ko) 2007-11-12
NO964699D0 (no) 1996-11-06
TW533214B (en) 2003-05-21
DK0773221T3 (da) 2000-07-10
CN1067392C (zh) 2001-06-20
CA2187409C (en) 2000-08-22
NO964699L (no) 1997-05-09
HUP9603072A3 (en) 1998-01-28
AU707443B2 (en) 1999-07-08
EP0773221B1 (de) 2000-04-05
ATE191482T1 (de) 2000-04-15
DE59604878D1 (de) 2000-05-11
KR970027048A (ko) 1997-06-24
RU2187508C2 (ru) 2002-08-20
EP0773221A1 (de) 1997-05-14
CH689831A5 (de) 1999-12-15
CA2187409A1 (en) 1997-05-08
AU7053396A (en) 1997-05-15
JPH09169759A (ja) 1997-06-30
KR100296162B1 (ko) 2001-09-10
HU9603072D0 (en) 1996-12-30
US5817659A (en) 1998-10-06
KR970027056A (ko) 1997-06-24
JP3382103B2 (ja) 2003-03-04
PT773221E (pt) 2000-09-29
CN1153176A (zh) 1997-07-02

Similar Documents

Publication Publication Date Title
ES2145360T3 (es) Sales cristalinas y estables de acido tetrahidrofolico.
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
BR0114584A (pt) Monohidrato cristalino, processos para a sua preparação e sua aplicação para a preparação de um medicamento
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
AR005458A1 (es) 2-oxo-y 2-tio-1,2-dihidroquinolinil-oxazolidinonas, procedimiento para su produccion, el uso de las mismas para la produccion de un medicamento ymedicamentos que los contienen
ES2159382T3 (es) Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones.
ES2172670T3 (es) Pirrolpirimidinas y procedimientos para su preparacion.
HN1999000124A (es) Derivados de pirazol substituido.
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
ES2183180T3 (es) Nuevos derivados de guanidina, procedimientos para su preparacion y su uso como medicamento.
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
AR015933A1 (es) Esmalte para unas con actividad antipsoriasica y procedimiento para su preparacion
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
ES2192680T3 (es) Nuevos derivados de vitamina d con sustituyentes carbo- o heterociclicos en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
ES2041705T3 (es) Procedimiento para la preparacion de 1-(4-hidroxi-3,5-di-terc-butil-benzoil)-homopiperazina y sus derivados.
ES2037808T3 (es) Procedimiento para la obtencion de medicamentos para la profilaxis y terapia de enfermedades producidas por retrovirus.
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
MX9301746A (es) Nuevos acidos 9-fluor-7-oxo-7h-pirido(1,2,3,-de)(1,4)-benzoxacin-6-carboxilicos y sus esteres, procedimiento para su preparacion y medicamentos que los contienen.
ES2139965T3 (es) Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 773221

Country of ref document: ES